Evidence map›Paper›PMID 33228611›Full record

ArticleBMC cancer2020

Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.

Min Wang, Shan Huang, Zefeng Chen, Zhiwei Han, Kezhi Li, Chuang Chen, Guobin Wu, Yinnong Zhao

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prognostic prediction and gene regulation network ofJournal of gastrointestinal oncology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Min WangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0002-5474-449X
Shan HuangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0001-8581-3649
Zefeng ChenDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0002-8446-4878
Zhiwei HanDepartment of Chinese Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0002-2669-2354
Kezhi LiDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0002-4205-4088
Chuang ChenDepartment of Chinese Medicine, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0001-5367-4349
Guobin WuDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.ORCID https://orcid.org/0000-0003-0505-9637
Yinnong ZhaoDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China. zhaoyinnong@gxmu.edu.cn.ORCID https://orcid.org/0000-0002-3080-1912
Guangxi Medical University · CN

Funding

Guangxi colleges and universities young and middle-aged teachers basic ability improvement project 2018KY0126The central government guides local science and technology development projects (local professional technology innovation platforms) GUIKE ZY1949017
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is among the deadliest forms of cancer. While RNA-binding proteins (RBPs) have been shown to be key regulators of oncogenesis and tumor progression, their dysregulation in the context of HCC remains to be fully characterized.

methodsData from the Cancer Genome Atlas - liver HCC (TCGA-LIHC) database were downloaded and analyzed in order to identify RBPs that were differentially expressed in HCC tumors relative to healthy normal tissues. Functional enrichment analyses of these RBPs were then conducted using the GO and KEGG databases to understand their mechanistic roles. Central hub RBPs associated with HCC patient prognosis were then detected through Cox regression analyses, and were incorporated into a prognostic model. The prognostic value of this model was then assessed through the use of Kaplan-Meier curves, time-related ROC analyses, univariate and multivariate Cox regression analyses, and nomograms. Lastly, the relationship between individual hub RBPs and HCC patient overall survival (OS) was evaluated using Kaplan-Meier curves. Finally, find protein-coding genes (PCGs) related to hub RBPs were used to construct a hub RBP-PCG co-expression network.

resultsIn total, we identified 81 RBPs that were differentially expressed in HCC tumors relative to healthy tissues (54 upregulated, 27 downregulated). Seven prognostically-relevant hub RBPs (SMG5, BOP1, LIN28B, RNF17, ANG, LARP1B, and NR0B1) were then used to generate a prognostic model, after which HCC patients were separated into high- and low-risk groups based upon resultant risk score values. In both the training and test datasets, we found that high-risk HCC patients exhibited decreased OS relative to low-risk patients, with time-dependent area under the ROC curve values of 0.801 and 0.676, respectively. This model thus exhibited good prognostic performance. We additionally generated a prognostic nomogram based upon these seven hub RBPs and found that four other genes were significantly correlated with OS.

conclusionWe herein identified a seven RBP signature that can reliably be used to predict HCC patient OS, underscoring the prognostic relevance of these genes.

Indexed as

Carcinoma, HepatocellularFemaleHumansLiver NeoplasmsMaleMiddle AgedPrognosisRNA-Binding ProteinsRNA-Binding ProteinsComprehensive bioinformatics analysisHepatocellular carcinomaPrognosisRNA binding protein

Identifiers

PMID33228611
PMCPMC7684760
OpenAlexW3110601261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.